tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Schrodinger price target lowered to $28 from $30 at KeyBanc
PremiumThe FlySchrodinger price target lowered to $28 from $30 at KeyBanc
1M ago
Hold Rating on Schrodinger Amid Uncertainty in Software Growth and Promising Drug Pipeline
Premium
Ratings
Hold Rating on Schrodinger Amid Uncertainty in Software Growth and Promising Drug Pipeline
2M ago
Schrodinger initiated with a Neutral at Goldman Sachs
Premium
The Fly
Schrodinger initiated with a Neutral at Goldman Sachs
2M ago
Schrodinger discontinues SGR-2921 clinical development program
PremiumThe FlySchrodinger discontinues SGR-2921 clinical development program
3M ago
Schrodinger initiated with an Overweight at Barclays
Premium
The Fly
Schrodinger initiated with an Overweight at Barclays
3M ago
Schrodinger’s Strong Financial Performance and Promising Pipeline Developments Justify Buy Rating
Premium
Ratings
Schrodinger’s Strong Financial Performance and Promising Pipeline Developments Justify Buy Rating
3M ago
Schrodinger sees Software revenue growth of 10%-15%
PremiumThe FlySchrodinger sees Software revenue growth of 10%-15%
4M ago
Meta upgraded, PNC Financial downgraded: Wall Street’s top analyst calls
Premium
The Fly
Meta upgraded, PNC Financial downgraded: Wall Street’s top analyst calls
5M ago
Schrodinger assumed with an Equal Weight at Morgan Stanley
Premium
The Fly
Schrodinger assumed with an Equal Weight at Morgan Stanley
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100